Aristo Bio-Tech

{
  "main_header": {
    "sid": 1003785,
    "name": "Aristo Bio-Tech",
    "stock_name": "Aristo Bio-Tech",
    "full_name": "Aristo Bio-Tech & Lifescience Ltd",
    "name_url": "stocks-analysis/aristo-bio-tech",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "89.30",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "89.30",
    "mcapval": "61.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "ARISTO",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE082101010",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": 4000,
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aristo-bio-tech-1003785-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Aristo Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aristo-bio-tech-fallingrising-3722297",
        "imagepath": "",
        "date": "2025-11-22 01:28:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance Compared to Benchmarks</strong></p>\n<p>Aristo Bio-Tech’s stock has experienced a significant decline over multiple timeframes when compared with the broader Sensex index. Over the past week, the stock fell by 5.77%, whereas the Sensex gained 0.61%. This negative trend intensified over the last month, with the stock dropping 9.26% against the Sensex’s modest 0.77% rise. Year-to-date figures further highlight the divergence: Aristo Bio-Tech is down 7.89%, while the Sensex has advanced by 10.25%. Over the last year, the stock’s decline deepened to 19.12%, contrasting sharply with the Sensex’s 11.64% gain. These figures indicate that the stock has underperformed the benchmark consistently, signalling investor caution or negative sentiment specific to the company or its s..."
      },
      {
        "title": "How has been the historical performance of Aristo Bio-Tech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-aristo-bio-tech-3704174",
        "imagepath": "",
        "date": "2025-11-15 00:27:39",
        "description": "Answer:\nThe historical performance of Aristo Bio-Tech shows a consistent growth trajectory in net sales and profitability over the past five years.\n\nBreakdown:\nAristo Bio-Tech's net sales have increased significantly from INR 165.76 crore in March 2022 to INR 318.09 crore in March 2025, reflecting a strong upward trend. Total operating income has followed a similar pattern, rising from INR 167.22 crore in March 2021 to INR 318.09 crore in March 2025. However, raw material costs have also escalated, reaching INR 295.60 crore in March 2025, which has impacted the operating profit margin, which decreased from 4.0% in March 2023 to 2.91% in March 2025. Despite this, the operating profit (PBDIT) has shown improvement, growing from INR 4.36 crore in March 2021 to INR 9.72 crore in March 2025. Profit before tax has also increased, reaching INR 5.47 crore in March 2025, while profit after tax rose to INR 4.06 crore..."
      }
    ],
    "total": 84,
    "sid": "1003785",
    "stock_news_url": "https://www.marketsmojo.com/news/aristo-bio-tech-lifescience-1003785"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aristo Bio-Tech & Lifescience Ltd has declared <strong>5%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Aristo Bio-Tech falling/rising?

2025-11-22 01:28:56

Recent Price Performance Compared to Benchmarks

Aristo Bio-Tech’s stock has experienced a significant decline over multiple timeframes when compared with the broader Sensex index. Over the past week, the stock fell by 5.77%, whereas the Sensex gained 0.61%. This negative trend intensified over the last month, with the stock dropping 9.26% against the Sensex’s modest 0.77% rise. Year-to-date figures further highlight the divergence: Aristo Bio-Tech is down 7.89%, while the Sensex has advanced by 10.25%. Over the last year, the stock’s decline deepened to 19.12%, contrasting sharply with the Sensex’s 11.64% gain. These figures indicate that the stock has underperformed the benchmark consistently, signalling investor caution or negative sentiment specific to the company or its s...

Read full news article

How has been the historical performance of Aristo Bio-Tech?

2025-11-15 00:27:39

Answer: The historical performance of Aristo Bio-Tech shows a consistent growth trajectory in net sales and profitability over the past five years. Breakdown: Aristo Bio-Tech's net sales have increased significantly from INR 165.76 crore in March 2022 to INR 318.09 crore in March 2025, reflecting a strong upward trend. Total operating income has followed a similar pattern, rising from INR 167.22 crore in March 2021 to INR 318.09 crore in March 2025. However, raw material costs have also escalated, reaching INR 295.60 crore in March 2025, which has impacted the operating profit margin, which decreased from 4.0% in March 2023 to 2.91% in March 2025. Despite this, the operating profit (PBDIT) has shown improvement, growing from INR 4.36 crore in March 2021 to INR 9.72 crore in March 2025. Profit before tax has also increased, reaching INR 5.47 crore in March 2025, while profit after tax rose to INR 4.06 crore...

Read full news article

View All News